help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mellor, S. L.
Right arrow Articles by Risbridger, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mellor, S. L.
Right arrow Articles by Risbridger, G. P.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 12 4851-4858
Copyright © 2000 by The Endocrine Society


Original Studies

Localization of Activin ßA-, ßB-, and ßC-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers of ßC-Subunit1

Sally L. Mellor, Mark Cranfield, Rainer Ries, John Pedersen, Belinda Cancilla, David de Kretser, Nigel P. Groome, Anthony J. Mason and Gail P. Risbridger

Monash Institute of Reproduction and Development (S.L.M., B.C., D.d.K., G.P.R.), Monash University, Melbourne, Victoria, Australia; School of Biological and Molecular Sciences, Oxford Brookes University (M.C., N.P.G.), Headington, Oxford, United Kingdom; BIOPHARM (R.R.), Heidelberg, Germany; Melbourne Pathology, Collingwood, Victoria, Australia (J.P.); and Department of Microbiology, Monash University (A.J.M.), Clayton, Victoria, Australia

Address all correspondence and requests for reprints to: Dr. Gail P. Risbridger, Monash Institute of Reproduction and Development, 27–31 Wright Street, Clayton 3168, Victoria, Australia. E-mail: gail.risbridger{at}med.monash.edu.au

Activin ligands are formed by dimerization of activin ßA- and/or ßB-subunits to produce activins A, AB, or B. These ligands are members of the transforming growth factor-ß superfamily and act as growth and differentiation factors in many cells and tissues. New additions to this family include activin ßC-, ßD-, and ßE-subunits. The aim of this investigation was to examine the localization of and dimerization among activin subunits; the results demonstrate that activin ßC can form dimers with activin ßA and ßB in vitro, but not with the inhibin {alpha}-subunit. Using a specific antibody, activin ßC protein was localized to human liver and prostate and colocalized with ßA- and ßB-subunits to specific cell types in benign and malignant prostate tissues. Activin C did not alter DNA synthesis of the prostate tumor cell line, LNCaP, or the liver tumor cell line, HepG2, in vitro when added alone or with activin A. Therefore, the capacity to form novel activin heterodimers (but not inhibin C) resides in the human liver and prostate. Activin A, AB, and B have diverse actions in many tissues, including liver and prostate, but there is no known biological activity for activin C. Thus, the evidence of formation of activin AC or BC heterodimers may have significant implications in the regulation of levels and/or biological activity of other activins in these tissues.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. Gold, N. Jetly, M. K. O'Bryan, S. Meachem, D. Srinivasan, S. Behuria, L. G. Sanchez-Partida, T. Woodruff, S. Hedwards, H. Wang, et al.
Activin C Antagonizes Activin A in Vitro and Overexpression Leads to Pathologies in Vivo
Am. J. Pathol., January 1, 2009; 174(1): 184 - 195.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Barakat, A. E O'Connor, E. Gold, D. M de Kretser, and K. L Loveland
Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice
Reproduction, September 1, 2008; 136(3): 345 - 359.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-G. Chen, Q. Wang, S.-L. Lin, C. D. Chang, J. Chung, and S.-Y. Ying
Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis.
Experimental Biology and Medicine, May 1, 2006; 231(5): 534 - 544.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Patella, D. J. Phillips, J. Tchongue, D. M. de Kretser, and W. Sievert
Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis
Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G137 - G144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Muenster, C. A. Harrison, C. Donaldson, W. Vale, and W. H. Fischer
An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties
J. Biol. Chem., November 4, 2005; 280(44): 36626 - 36632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Chen, M. Nomura, H. Morinaga, E. Matsubara, T. Okabe, K. Goto, T. Yanase, H. Zheng, J. Lu, and H. Nawata
Modulation of Androgen Receptor Transactivation by FoxH1: A NEWLY IDENTIFIED ANDROGEN RECEPTOR COREPRESSOR
J. Biol. Chem., October 28, 2005; 280(43): 36355 - 36363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Wada, A. Maeshima, Y.-Q. Zhang, Y. Hasegawa, H. Kuwano, and I. Kojima
Assessment of the function of the {beta}C-subunit of activin in cultured hepatocytes
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E247 - E254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Harrison, P. C. Gray, W. H. Fischer, C. Donaldson, S. Choe, and W. Vale
An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors
J. Biol. Chem., July 2, 2004; 279(27): 28036 - 28044.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. L. Carey, L. M. Sasur, H. Kawakubo, V. Gupta, B. Christian, P. M. Bailey, and S. Maheswaran
Mutually Antagonistic Effects of Androgen and Activin in the Regulation of Prostate Cancer Cell Growth
Mol. Endocrinol., March 1, 2004; 18(3): 696 - 707.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Vejda, N. Erlach, B. Peter, C. Drucker, W. Rossmanith, J. Pohl, R. Schulte-Hermann, and M. Grusch
Expression of activins C and E induces apoptosis in human and rat hepatoma cells
Carcinogenesis, November 1, 2003; 24(11): 1801 - 1809.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. L. Mellor, E. M. A. Ball, A. E. O'Connor, J.-F. Ethier, M. Cranfield, J. F. Schmitt, D. J. Phillips, N. P. Groome, and G. P. Risbridger
Activin {beta}C-Subunit Heterodimers Provide a New Mechanism of Regulating Activin Levels in the Prostate
Endocrinology, October 1, 2003; 144(10): 4410 - 4419.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Chabicovsky, K. Herkner, and W. Rossmanith
Overexpression of Activin {beta}C or Activin {beta}E in the Mouse Liver Inhibits Regenerative Deoxyribonucleic Acid Synthesis of Hepatic Cells
Endocrinology, August 1, 2003; 144(8): 3497 - 3504.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying
Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin
Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. P. Risbridger, J. F. Schmitt, and D. M. Robertson
Activins and Inhibins in Endocrine and Other Tumors
Endocr. Rev., December 1, 2001; 22(6): 836 - 858.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society